⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 25, 2010Leukemia & lymphoma/Leukemia and lymphoma

Genetic variation in tumor necrosis factor and risk of diffuse large B-cell lymphoma and follicular lymphoma: differences between subgroups in Swedish patients

Ulf Thunberg Gunilla Enblad Ingela Turesson Mattias Berglund

View at Publisher

Ask AI

Bookmark

Share

Abstract

Non-Hodgkin lymphomas (NHLs) are tumors closely related to the immune system. The two most common subtypes of NHL are diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). The impact ...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Thunberg et al. (2010) studied this question.

synapsesocial.com/papers/6a829e461a90e54f711c22f5 https://doi.org/10.3109/10428194.2010.492486

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Tumor necrosis factor promoter gene polymorphism associated with increased susceptibility to non‐Hodgkin's lymphomasCase-Control Study · 2006 · 39 citations
2Genetic variants in immunoregulatory genes and risk for childhood lymphomasCase-Control Study · 2009 · 34 citations
3Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma StudyRegistry Study · 2006 · 125 citations
4Genetic Variation in Tumor Necrosis Factor and the Nuclear Factor-κB Canonical Pathway and Risk of Non-Hodgkin's LymphomaCase-Control Study · 2008 · 72 citations
5Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab eraOriginal Research · 2008 · 70 citations

Common Gene Variants in the Tumor Necrosis Factor (TNF) and TNF Receptor Superfamilies and NF-kB Transcription Factors and Non-Hodgkin Lymphoma Risk2009
SNPstream <sup>®</sup> UHT: Ultra-High Throughput SNP Genotyping for Pharmacogenomics and Drug Discovery2002
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray2003
Care pathway of patients with second-line large B-cell lymphoma treated with CAR T-cell therapies in FranceLeukemia & lymphoma/Leukemia and lymphoma · 2026
Metronomic per oral decitabine-cedazuridine plus venetoclax in acute myeloid leukemiaLeukemia & lymphoma/Leukemia and lymphoma · 2026

More from Leukemia & lymphoma/Leukemia and lymphoma

More from Uppsala University